Tricida Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced the pricing of its public offering of 5,600,000 shares of its…
Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced the pricing of its public offering of 5,600,000 shares of its…
OSAKA, Japan, AMSTERDAM, & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi,…
Sandoz is resubmitting its Biologics License Application for a proposed biosimilar pegfilgrastim to the US FDA
–Addition of Experienced Executive to Leadership Team– NEWTOWN, Pa.–(BUSINESS WIRE)–Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a private biopharmaceutical company founded to…
LabCorp joins QIAGEN’s “Day-One” program designed to help deliver precision medicine to patients faster HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)—-QIAGEN…
Additional Perficient presentations will focus on artificial intelligence (AI) and machine learning in clinical data management and medical coding ST.…
Research published in Nature utilizes cryo-EM to determine structure of critical metabolic protein CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company…
BALERNA, Switzerland–(BUSINESS WIRE)–APR Applied Pharma Research’s patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other…
EUR 21m Series A secured with international investor syndicate co-led by V-Bio Ventures (Belgium) and Advent France Biotechnology (France), and…
Successful manufacturing and release of GMP vials of UCARTCS1 NEW YORK–(BUSINESS WIRE)–Regulatory News: Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…